Canada Markets close in 4 hrs 31 mins

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07660.0000 (0.00%)
As of 9:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.0766
Open0.0749
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0766 - 0.0766
52 Week Range0.0735 - 0.2666
Volume24
Avg. Volume7,926
Market Cap11.826M
Beta (5Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants

    VANCOUVER, BC / ACCESSWIRE / September 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has arranged a non-brokered private placement (the "Placement") and the exercise of 4,900,000 warrants, for total combined proceeds of $276,550.

  • ACCESSWIRE

    Neutrisci Provides Update on Tabletz Developments

    VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide an update on previously announced projects.

  • ACCESSWIRE

    Neutrisci Provides Update on Tabletz and Previously Announced Project Development

    VANCOUVER, BC / ACCESSWIRE / July 7, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide an update on previously announced projects.